KOCAA
Knights of Columbus Asset Advisors’s Viking Therapeutics VKTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Sell |
18,459
-270
| -1% | -$7.16K | 0.03% | 280 |
|
|
2025
Q1 | $452K | Buy |
18,729
+497
| +3% | +$12K | 0.03% | 266 |
|
|
2024
Q4 | $734K | Buy |
18,232
+48
| +0.3% | +$1.93K | 0.05% | 253 |
|
|
2024
Q3 | $1.15M | Sell |
18,184
-24,070
| -57% | -$1.52M | 0.08% | 234 |
|
|
2024
Q2 | $2.24M | Buy |
42,254
+418
| +1% | +$22.2K | 0.15% | 199 |
|
|
2024
Q1 | $3.43M | Sell |
41,836
-39,851
| -49% | -$3.27M | 0.25% | 145 |
|
|
2023
Q4 | $1.52M | Buy |
81,687
+41,130
| +101% | +$765K | 0.1% | 242 |
|
|
2023
Q3 | $449K | Buy |
40,557
+1,226
| +3% | +$13.6K | 0.04% | 273 |
|
|
2023
Q2 | $638K | Buy |
+39,331
| New | +$638K | 0.06% | 265 |
|